Life Science Research Services Market Size, Share and Trends 2026 to 2035

Revenue, 2025

USD 35.37 Bn

Forecast Year, 2035

USD 96.26 Bn

CAGR, 2026 - 2035

10.53%

Report Coverage

Global

What is Life Science Research Services Market Size?

The global life science research services market size is calculated at USD 35.37 billion in 2025 and is predicted to increase from USD 39.09 billion in 2026 to approximately USD 96.26 billion by 2035, expanding at a CAGR of 10.53% from 2026 to 2035. The life science research services market is witnessing unprecedented growth, driven by the rapid expansion of biotech startups and a surge in R&D spending.

Market Highlights

• North America dominated the market, holding the largest market share in 2025.
• The Asia-Pacific is expected to grow at the fastest CAGR between 2026 and 2035.
• By service type, the clinical research services segment held the major market share in 2025.
• By service type, the genomics & proteomics services segment is growing at a remarkable CAGR between 2026 and 2035.
• By therapeutic area, the oncology segment contributed the highest market share in 2025.
• By therapeutic area, the rare diseases segment is expanding at a significant CAGR between 2026 and 2035.
• By end user, the pharmaceutical companies segment held the largest market share in 2025.
• By end user, the biotechnology companies segment is expected to expand at a remarkable growth rate between 2026 and 2035.
• By technology platform, the high-throughput screening segment held the largest share in the life science research services market during 2025.
• By technology platform, the AI-driven drug discovery tools segment is set to grow at a notable CAGR between 2026 and 2035.
• The global life science research services market comprises outsourced scientific, technical, and analytical services supporting drug discovery, preclinical research, clinical development, molecular biology, genomics, proteomics, bioinformatics, and regulatory documentation.
• CROs, academic institutes, private laboratories, and specialized service providers to pharmaceutical, biotechnology, medical device, diagnostics, and research organizations provide these services.

Life Science Research Services Market Overview

The global life science research services market comprises outsourced scientific, technical, and analytical services that support every stage of biomedical innovation. These services span drug discovery , preclinical research, and clinical development, as well as molecular biology, genomics , proteomics , and bioinformatics . They also include regulatory documentation, assay development, biomarker analysis, and laboratory workflow support. This broad scope reflects the shifting preference of life science companies toward specialized partners that can accelerate research timelines and improve scientific depth.

CROs, academic institutes, private laboratories, and specialized service providers deliver these offerings to pharmaceutical, biotechnology, medical device , diagnostics, and research organizations. Each group contributes distinct capabilities. CROs manage large-scale clinical operations, toxicology studies, and statistical analysis. Academic institutes provide advanced research expertise, niche biological models, and access to high-end instrumentation. Private laboratories support routine testing, assay validation, and quality control. Specialized providers focus on genomics sequencing, proteomic profiling, AI-based drug discovery, and data interpretation.

How Are AI-Driven Innovations Reshaping the Life Science Research Services Market?

As technology continues to evolve, the integration of Artificial Intelligenc e is significantly accelerating the growth of the life science research services market by accelerating drug discovery, enabling more personalized patient care, and streamlining clinical trials. AI integration in life science research services helps efficiently analyze massive datasets for faster insights, automate tasks, and improve accuracy. AI algorithms can analyze massive datasets of biological and chemical information to identify promising drug targets, design novel compounds, and predict molecular interactions. AI has reshaped the entire life sciences and healthcare lifecycle, from redefining research and development to streamlining clinical trial design and reshaping commercialization strategies.

• In October 2025, Anthropic launched Claude Life Sciences to support AI-driven research. Digital tools allow researchers to use Claude to conduct literature reviews, develop hypotheses, analyze data, and draft a regulatory submission.

Life Science Research Services Market Outlook

[[market_outlook]]

Market Scope

Life Science Research Services Market Segmental Insights

[[segment_insights]]

Life Science Research Services Market Regional Insights

[[regional_insights]]

Recent Developments:

• In January 2025, IQVIA, a leading global provider of clinical research services, commercial insights, and healthcare intelligence, announced a strategic collaboration with NVIDIA to help realize the potential of AI in healthcare and life sciences. This collaboration between IQVIA and NVIDIA will help accelerate IQVIA Healthcare-grade AI, enabling new levels of agentic automation of complex, time-consuming workflows across the therapeutic life cycle, with the precision, scalability, and trust required by IQVIA's customers.
• In August 2025, IQVIA and Flagship Pioneering announced a strategic collaboration to accelerate the development of breakthrough life sciences companies. The collaboration will help the Flagship ecosystem of biopharma companies accelerate innovation by offering access to IQVIA's comprehensive capabilities, including unparalleled information assets, analytics, and domain expertise across the drug development life cycle from discovery through early development and commercialization.

Life Science Research Services Market Companies

• Thermo Fisher Scientific
• Danaher Corporation
• Merck KGaA
• Agilent Technologies
• F. Hoffmann-La Roche Ltd.
• Becton, Dickinson and Company
• Bio-Rad Laboratories
• Bruker Corporation
• Qiagen N.V.

Life Science Research Services MarketSegments Covered in the Report

[[segment_covered]]